GSK(GSK)
GSK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $33.95B | $35.71B | $36.87B | $38.43B | $38.00B |
| Low | $33.83B | $33.55B | $35.28B | $37.45B | $37.03B |
| High | $34.15B | $36.63B | $39.84B | $39.80B | $39.36B |
| EBITDA Avg | $11.37B | $11.96B | $12.35B | $12.87B | $12.73B |
| Low | $11.33B | $11.24B | $11.82B | $12.54B | $12.40B |
| High | $11.44B | $12.27B | $13.35B | $13.33B | $13.18B |
| EBIT Avg | $9.31B | $9.79B | $10.11B | $10.54B | $10.42B |
| Low | $9.28B | $9.20B | $9.68B | $10.27B | $10.16B |
| High | $9.37B | $10.05B | $10.93B | $10.92B | $10.79B |
| Net Income Avg | $7.39B | $8.01B | $8.49B | $8.89B | $9.06B |
| Low | $7.23B | $7.57B | $7.67B | $8.60B | $8.76B |
| High | $7.55B | $8.44B | $9.30B | $9.31B | $9.48B |
| EPS Avg | $3.58 | $3.88 | $4.09 | $4.32 | $4.40 |
| Low | $3.51 | $3.68 | $3.73 | $4.18 | $4.26 |
| High | $3.67 | $4.10 | $4.52 | $4.52 | $4.61 |
| Analysts (Rev / EPS) | 10 / 6 | 14 / 6 | 18 / 9 | 10 / 3 | 9 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $8.91B | $8.98B | $8.18B | $8.81B | $9.29B | $9.30B |
| Low | $8.45B | $8.55B | $7.90B | $8.51B | $8.96B | $8.98B |
| High | $9.31B | $9.25B | $8.41B | $9.06B | $9.54B | $9.56B |
| EBITDA Avg | $2.98B | $3.01B | $2.74B | $2.95B | $3.11B | $3.12B |
| Low | $2.83B | $2.86B | $2.65B | $2.85B | $3.00B | $3.01B |
| High | $3.12B | $3.10B | $2.82B | $3.03B | $3.20B | $3.20B |
| EBIT Avg | $2.44B | $2.46B | $2.24B | $2.42B | $2.55B | $2.55B |
| Low | $2.32B | $2.34B | $2.17B | $2.33B | $2.46B | $2.46B |
| High | $2.55B | $2.54B | $2.31B | $2.48B | $2.62B | $2.62B |
| Net Income Avg | $2.12B | $1.14B | $2.17B | $2.19B | $2.41B | $1.17B |
| Low | $1.96B | $1.02B | $2.07B | $2.09B | $2.30B | $1.12B |
| High | $2.18B | $1.21B | $2.24B | $2.27B | $2.50B | $1.22B |
| EPS Avg | $1.04 | $0.56 | $1.07 | $1.08 | $1.19 | $0.58 |
| Low | $0.97 | $0.50 | $1.02 | $1.03 | $1.13 | $0.55 |
| High | $1.07 | $0.60 | $1.10 | $1.12 | $1.23 | $0.60 |
| Analysts (Rev / EPS) | 4 / 3 | 4 / 2 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 |